Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Inflammatory demyelinating central nervous system diseases in childhood: clinical and paraclinical profiles in 133 patients.
Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells.
Participation as an Outcome in Multiple Sclerosis Falls-Prevention Research: Consensus Recommendation from the International MS Falls Prevention Research Network.
Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model.
Mast Cell and Autoimmune Diseases.
Moyamoya disease in a patient with neuromyelitis optica.
Characterization of dose-response for count data using a generalized MCP-Mod approach in an adaptive dose-ranging trial.
ADvanced IMage Algebra (ADIMA): a novel method for depicting multiple sclerosis lesion heterogeneity, as demonstrated by quantitative MRI.
Stability of intraindividual variability as a marker of neurologic dysfunction in relapsing remitting multiple sclerosis.
MS patients must have access to the best treatment options.
Intradetrusorial Botulinum Toxin in Patients with Multiple Sclerosis: A Neurophysiological Study.
Aging of the cingulum in the human brain: Preliminary study of a diffusion tensor imaging study.
Whole-body cryostimulation (cryotherapy) provides benefits for fatigue and functional status in multiple sclerosis patients. A case-control study.
Brain radiation and possible presentation of multiple sclerosis.
Dose-related effects of vitamin D on immune responses in patients with clinically isolated syndrome and healthy control participants: study protocol for an exploratory randomized double- blind placebo-controlled trial.
Charcot-Marie-Tooth disease: Genetic and clinical spectrum in a Spanish clinical series.
Matrix Metalloproteinases, New Insights into the Understanding of Neurodegenerative Disorders.
Waldenstrom's Macroglobulinaemia Presenting as Demyelinating Polyradiculoneuropathy.
PML after natalizumab discontinuation: Few and true?
Characterization of Microcirculation in Multiple Sclerosis Lesions by Dynamic Texture Parameter Analysis (DTPA).
Nerve ultrasound score in distinguishing chronic from acute inflammatory demyelinating polyneuropathy.
Autoantibodies in neuroimmunological diseases; relevance of fine specificity.
Olfactory dysfunction in patients with neuromyelitis optica.
Interferon-beta-induced pulmonary sarcoidosis in a 30-year-old woman treated for multiple sclerosis: a case report.
Erratum: microRNA dysregulation in multiple sclerosis.
Pages
« first
‹ previous
…
567
568
569
570
571
572
573
574
575
…
next ›
last »